Cargando…
Informing real-world practice with real-world evidence: the value of PRECIS-2
Real-world evidence is needed to inform real-world practice. Pragmatic controlled trials are intended to provide such evidence by assessing the effectiveness of medicines and other interventions in real-world settings, as opposed to explanatory trials that assess efficacy in highly controlled settin...
Autores principales: | Neta, Gila, Johnson, Karin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963183/ https://www.ncbi.nlm.nih.gov/pubmed/29783964 http://dx.doi.org/10.1186/s12916-018-1071-1 |
Ejemplares similares
-
Real-World Evidence: Pharmacoepidemiology for Daily Clinical Practice—An Experience from Colombia
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2020) -
Real World Evidence in Medical Cannabis Research
por: Banerjee, Rishi, et al.
Publicado: (2021) -
Is there an added value in more real‐world cannabinoids studies?
por: Eisenberg, Elon
Publicado: (2022) -
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
por: Dai, Wei Fang, et al.
Publicado: (2022) -
The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity
por: Khosla, Sajan, et al.
Publicado: (2021)